CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 45 enrolled
Drug / intervention
Femtosecond Laser Assisted Cataract Surgery w/ Catalys Laser +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01878838
NCT01878838N/ACompleted
CompareCT.gov

A Prospective Randomized Controlled Clinical Trial Comparing the Intra-operative Effects, Safety, Efficacy and Performance of Two Commercially Available Laser Systems in Patients Undergoing Femtosecond Laser-Assisted Cataract Surgery.

Steven H. Linn, OD·interventional·Posted Jun 17, 2013·Updated Mar 11, 2025

In Brief

A clinical study evaluating Femtosecond Laser Assisted Cataract Surgery w/ Catalys Laser and Femtosecond Laser Assisted Cataract Surgery w/ LenSx Laser for Nuclear Sclerosis of the Lens and 2 related conditions. Completed, enrolled 45 participants across 1 site.

Detailed Summary

This study compares two FDA approved Cataract Lasers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNuclear Sclerosis of the Lens, Posterior Subcapsular Cataract, Cortical Cataract
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 17, 2013
Enrollment StartApr 1, 2013
Primary CompletionDec 1, 2013
Study CompletionJan 1, 2014
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 13.0 years ago

Interventions

Femtosecond Laser Assisted Cataract Surgery w/ Catalys Laserprocedure

Cohort subjects will undergo Femtosecond Laser Assisted Cataract Surgery in both eyes, with the Optimedica Catalys laser on one eye, and the Alcon LensX laser on the other. First eyes will be randomized.

Femtosecond Laser Assisted Cataract Surgery w/ LenSx Laserprocedure

Cohort subjects will undergo Femtosecond Laser Assisted Cataract Surgery in both eyes, with the Optimedica Catalys laser on one eye, and the Alcon LensX laser on the other. First eyes will be randomized.